Osimertinib/osimertinib manufacturer

Osimertinib is produced by AstraZeneca, a world-renowned biopharmaceutical company headquartered in Cambridge, UK. AstraZeneca is a multinational pharmaceutical company with a long history and rich experience, dedicated to developing, manufacturing and marketing a variety of innovative medicines to improve the quality of life of patients around the world.

As a leading biopharmaceutical company, AstraZeneca focuses on the research and development of innovative medicines for the treatment of cancer, cardiovascular diseases, respiratory diseases, autoimmune diseases and other fields. Osimertinib/OsimertinibAs a targeted therapy drug developed by AstraZeneca, it represents one of the company's innovative achievements in the field of cancer treatment.

AstraZeneca has multiple R&D centers, production bases and sales networks around the world to meet the medical needs of different countries and regions. The company has a large team of scientists, doctors, engineers and professionals dedicated to continuous innovation, advancing medical science and providing patients with more effective treatment options.

As the manufacturer of Osimertinib/Osimertinib, AstraZeneca assumes strict quality control and regulatory responsibilities to ensure the safety, effectiveness and quality stability of the drug. The company has invested heavily in R&D and production to ensure the continued supply of Osimertinib and its other drugs, and continues to improve and optimize the production process to meet growing market demand.

In addition toosimertinib/osimertinib, AstraZeneca also produces and sells many other important drugs, including cardiovascular drugs, respiratory drugs, anti-cancer drugs, etc. The company's mission is to provide patients with longer and healthier lives through innovative medical solutions, and the success of Osimertinib is one of the important milestones for AstraZeneca in this mission.